Earnings / Healthcare
Abbott holds adjusted profit guidance but trims its 2026 sales growth target to about 6.0%
Third-quarter sales rose 14.5% from a year earlier to $13.01 billion, or 7.0% on the comparable basis, while adjusted diluted EPS of $1.42 compared with $1.30 and GAAP EPS fell to $0.53 from $0.94 on legal and amortization charges.